On September 27, Gelunhui announced that in order to strengthen and enhance the stability and bargaining power of the upstream supply chain of medical beauty, further improve the cost-effectiveness and profitability of the company's products, on September 27, 2024, it signed a conditional agreement with Langxi Aesthetic (Beijing) Technology Development Co., Ltd. (referred to as 'Langxi Aesthetic'), Wuhu Boheng No. 3 Entrepreneurship Investment Partnership Enterprise (Limited Partnership) (referred to as 'Boheng No. 3') on the joint venture contract between Langxi Aesthetic (Beijing) Technology Development Co., Ltd., Lancy Co., Ltd., and Wuhu Boheng No. 3 Entrepreneurship Investment Partnership Enterprise (Limited Partnership) on Langxi Ziyin (Beijing) Medical Equipment Co., Ltd., Lancy Co., Ltd., Boheng No. 3 and Langxi Aesthetic intend to contribute 15 million yuan, 20 million yuan, and 6.5 million yuan respectively, to establish Langxi Ziyin (Beijing) Medical Equipment Co., Ltd. Langxi Ziyin is mainly engaged in the production and operation of Class III medical instruments, with a registered capital of 100 million yuan.
朗姿股份(002612.SZ)：拟参与设立朗曦姿颜
Lancy Co.,Ltd. (002612.SZ): Intends to participate in the establishment of Lancy Xi Zi Yan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.